SCHEMBL6804128

SCHEMBL6804128

O=[C]Cc1ccc(CCc2ncco2)cc1

nearest known ligand 0.36

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CES1 P23141 4/20 0.36
FAAH O00519 1/20 0.33
NCEH1 Q6PIU2 1/20 0.33
CYP1B1 Q16678 1/20 0.32
KCNJ1 P48048 1/20 0.31
KCNH2 Q12809 1/20 0.31
EDNRB P24530 1/20 0.30
EDNRA P25101 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL874347 0.78
SCHEMBL344823 0.77 CES1 (0.46) CES1FAAHNCEH1KCNH2
SCHEMBL343820 0.75 CES1 (0.35) CES1FAAHNCEH1KCNJ1KCNH2
SCHEMBL29086344 0.75 CYP1B1 (0.32) CES1FAAHNCEH1CYP1B1
SCHEMBL30443790 0.75 TAAR1 (0.47)
SCHEMBL1627810 0.74
Formamide SCHEMBL28728347 0.72 CES1 (0.43) CES1FAAHNCEH1
SCHEMBL11139354 0.68 CYP3A4 (0.42)
SCHEMBL659550 0.68
SCHEMBL27672051 0.68 MAOA (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6770647-B2 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-03 US disclosed
WO-2003016248-A2 BICYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$G(A) CONVERTING ENZYME (TACE) BRISTOL-MYERS SQUIBB COMPANY PATENT DEPARTMENT (US) 2003-02-27 WO disclosed